Antimicrobial therapy for shigellosis: Issues on antimicrobial resistance

Japanese Journal of Medical Science and Biology

Volumn 51, Issue SUPPL. 1, 1998, Pages

  Salam, Mohammed Abdus ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; DRUG MECHANISM; MULTIDRUG RESISTANCE; SHIGELLOSIS;

EID: 0032406681     PISSN: 00215112     EISSN: None     Source Type: Journal    
DOI: 10.7883/yoken1952.51.supplement1_s43     Document Type: Conference Paper

References (98)

1. Keusch, G.T. and Bennish, M.L. (1989): Shigellosis: recent progress, persietent problems and research issue. Pediatr Infect Dis J 8 : 713-719.
2. Committee on Issues and Priorities for New Vaccine Development. The burden of disease resulting from diarrhea. In: Katz SL; ed. New Vaccine Development: Establishing Priorities. Volume 2. Diseases of Importance in Developing Countries. Washington, DC; National Academy Press; 1986 : 165.
3. Bennish, M.L, Harris, J.R, Wojtyniak, B.J. and Streulens, M.J. (1990): Death in shigellosis: incidence and risk factors in hospitalizd patients. J Infect Dis 161 : 500-506.
4. Bennish, M.L. and Wojtyniak, B.J. (1991): Mortality due to shigellosis: community and hospital data. Rev Infect Dis 13 (suppl 4) : S245-S251.
5. Henry, F.J., Alam, N. and Aziz, K.M.S., et al. (1987): Dysentery, not watery diarrhea, is associated with stunting in Bangladeshi children. Hum Nutr Clin Nutr 41C : 243-249.
6. Ries, A.A., Wells, J.G., Olivola, D., Ntakibirora, M., Nyandwi, S., Ntibakivayo, M., Ivey, C.B., Greene, K.D., Tenover, F.C., Wahlquist, S.P., Griffin, P.M. and Tauxe, R.V. (1994): Epidemic Shigella dysenteriae type 1 in Burundi: Panresistance and implications for prevention. J Infect Dis 169 : 1035-1041.
7. Goma Epidemiology Group. (1995): Public health impact of Rwandan refugee crisis: what happened in Goma, Zaire, in July, 1994. Lancet 345 : 339-344.
8. Marberg, K., Altmann, G. and Eshkol-Bruck, A. (1958): Observations on resistance to sulfadiazine and antibioics in shigellosis. Am J Trop Med Hyg 7 : 51-57.
9. Weissman, J.B., Gangarosa, E.J. and DuPont, H.L. (1973): Changing needs in the antimicrobial therapy of shigellosis. J Infect Dis 127 : 611-613.
10. Rabbani, G.H., Gilman, R.H. and Spira, W.M. (1983): Intestinal fluid loss in Shigella dysentery: role of oral rehydration therapy. Lancet (letter) I : 654.
11. Mathan, M.M. and Mathan, V.I. (1985): Local Shwartzman reaction in the rectal mucosa in acute diarrhea. J Pathol 146 : 179-187.
12. Anand, B.S., Malhotra, V., Bhattacharya, S.K., Datta, P., Datta, D., Sen, D., Bhattacharya, M.K., Mukherjee, P.P. and Pal, S.C. (1986): Rectal histology in acute bacillary dysentery. Gastroenterol 90 : 654-660.
13. Mathan, M.M. and Mathan, V.I. (1991): Morphology of rectal mucosa of patients with shigellosis. J Infect Dis 13 (Suppl 4) : S314-S318.
14. Molla, A.M., Molla, A., Sarker, S.A. and Rahaman, M.M. (1983): Food intake during and after recovery from diarrhea. In: Chen, L.C., Scrimshaw, N.S., eds. Interactions of diarrhea and malnutrition. Pathophysiology, epidemiology and interventions. New York: Plenum, 113-123.
15. Molla, A., Molla, A.M., Sarker, S.A., Khatun, M. and Rahaman, M.M. (1983): Effects of diarrhea on absorption of macronutrients during the acute stage and after recovery. In: Chen, L.C., Scrimshaw, N.S., eds. Interactions of diarrhea and malnutrition. Pathophysiology, epidemiology and interventions. New York: Plenum, 143-154.
16. Khan, W.A., Salam, M.A. and Bennish, M.L. (1995): C reactive protein and prealbumin as markers of disease activity in shigellosis. Gut 37 : 402-405.
17. Rahaman, M.M. and Wahed, M.A. (1983): Direct nutrient loss and diarrhea. In: Chen, L.C., Scrimshaw, N.S., eds. Interactions of diarrhea and malnutrition. Pathophysiology, epiderniology and interventions. New York: Plenum, 155-160.
18. Bennish, M.L., Salam, M.A. and Wahed, M.A. (1993): Enteric protein loss during shigellosis. Am J Gastroenterol 88 : 53-57.
19. Bennish, M.L., Azad, A.K., Rahman, O. and Phillips, R.E. (1990): Hypoglycemia during diarrhea in childhood. New Eng J Med 322 : 1357-1363.
20. Marshall, E.K., Bratton, A.C., Edwrads, L.B. and Walker, E. (1941): Sulfanilylguanidine in the treatment of acute bacillary dysentery in children. Bull Johns Hopkins Hosp 68 : 94-111.
21. Hardy, A.V., Watt, J., Peterson, J. and Schlosser, E. (1942): Studies of the acute diarrhoeal diseases. VIII. Sulfaguanidine in the control of Shigella dysenteriae infections. Public Health Rep 57 : 529-535.
22. Hardy, A.V., Burns, W. and Decapito, T. (1943): Studies of the acute diarrhoeal diseases. XA. Cultural observations on the relative efficacy of sulfonamides in Shigella dysenteriae infections. Public Health Rep 58 : 689-693.
23. Salam, M.A. and Bennish, M.L. (1991): Antimicrobial therapy for shigellosis. Rev Infect Dis 13 (suppl 4) : S332-S341.
24. Speelman, P., Kabir, I. and Islam, M. (1984): Distribution and spread of colonic lesions in shigellosis.: a colonoscopic study. J Infect Dis 150 : 899-903.
25. Levine, M.M., DuPont, H.L., Formal, S.B., Hornick, R.B., Takauchi, A., Gangarosa, E.J., Snyder, M.J. and Libonati, J.P. (1973): Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J Infect Dis 127 : 261-270.
26. DuPont, H.L., Hornick, R.B., Dawkins, A.T., Snyder, M.J. and Formal, S.B. (1969): The response of man to virulent Shigella flexneri 2a. J Infect Dis 119 : 296-299.
27. Gangarosa, E.J., Perera, D.R., Mata, L.J., Mendizábal-Morris, C., Guzmán, G. and Reller, L.B. (1970): Epidemic shiga bacillus dysentery in Central America. II. Epidemiological studies in 1969. J Infect Dis 122 : 181-190.
28. Rahaman, M.M., Khan, M.U., Aziz, K.M.S., Islam, M.S. and Kibriya, A.K.M.G. (1975): An outbreak of dysentery caused by Shigella dysenteriae type 1 on a coral island in the Bay of Bengal. J Infect Dis 132 : 15-19.
29. Rowe, B. and Threlfall, E.J. (1984): Drug resistance in Gram-negative aerobic bacilli. Br Med J. 40 : 68-76.
30. Haltalin, K.C., Nelson, J.D., Ring, R. 3rd., Sladoje, M. and Hinton, L.V. (1967): Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo. J Pediatr 70 : 970-981.
31. Butler, T., Islam, M.R., Azad, M.A.K. and Jones, P.K. (1987): Risk factors for development of hemolytic uremic syndrome during shigellosis. J Pediatr 110 : 894-897.
32. Carter, A.O., Borczyk, A.A. and Carlson, J.A.K. (1987): A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home. New Eng J Med 317 : 1496-1500.
33. Pavia, A.T., Nichols, C.R. and Green, D.P. (1990): Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J Pediatr 116 : 544-551.
34. Bell, B.P., Griffin, P.M., Lozano, P., Christie, L., Kobayashi, J.M. and Tarr, P.I. (1997): Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatr (Electronic article) 100 : 12-
35. Salam, M.A. (1994): Shigellosis: Chemotherapeutic strategies. Proceedings to 4th West Pacific Congress on Chemotherapy and Infectious Diseases. JAMA (SEA; Suppl December) 50-54.
36. Salam, M.A., Seas, C., Khan, W.A. and Bennish, M.L. (1995): Treatment of shigellosis: IV. Cefixime is ineffective in shigellosis in adults. Ann Intern Med 123 : 505-508.
37. Bennish, M.L., Salam, M.A., Khan, W.A. and Khan, A.M. (1992): Treatment of shigellosis. III. Comparison of one-or two-dose ciprofloxacin with standard 5 day therapy. A randomized, blinded trial. Ann Intern Med 117 : 727-734.
38. Khan, W.A., Seas, C., Dhar, U., Salam, M.A. and Bennish, M.L. (1997): Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Ann Intern Med 126 : 697-703.
39. Girard, A.F., Girard, D., English, A.R., Gootz, T.D., Cimochowski, C.R., Faiella, J.A., Kaskell, S.L. and Retsema, J.A. (1987): Pharmacokinetic and in vivo studies with azithromycin. Antimicrob Agents Chemother 31 : 1948-1954.
40. Panteix, G., Guillaumond, B., Harf, R., Desbos, A., Sapin, V., Leclercq, M. and Perin-Fayolle, M. (1993): In vitro concentration of azithromycin in human phagocytic cells. J Antimicrob Chemother 31 (Suppl E) : 1-4.
41. Bennish, N.W., Salam, M.A., Haider, R. and Barza, M. (1990): Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin. J Infect Dis 162 : 711-716.
42. Coleman, K., Athalye, M., Clancey, A., Davison, M., Payne, D., Perry, C.R. and Chopra, I. (1994): Bacterial resistance mechanisms as therapeutic targets. J Antimicrob Chemother 33 : 1091-1116.
43. Ameyes, S.G. and Gemmell, C.G. (1992): Antibiotic resistance in bacteria. J Med Microbiol 36 : 4-29.
44. Neu, H.C. (1992): The crisis in antibiotic resistance. Science 257 : 1064-1073.
45. Nelson, J.D., Kusmiesz, H., Jackson, L.H. and Woodman, F. (1976): Trimethoprim-sulfamethoxazole therapy for shigellosis. JAMA 235 : 1239-1243.
46. Chang, M.J., Dunke, L.M., Van Reken, D., Anderson, D., Wong, M.L. and Feigin, R.D. (1977): Trimethoprim-sulfamethoxazole compared to ampicillin in the treatment of shigellosis. Pediatr 59 : 726-729.
47. Yunus, M., Rahman, A.S.M.M., Farooque, A.S.G. and Glass, R.I. (1982): Clinical trial of ampicillin v. trimethoprim-sulphamethoxazole in the treatment of Shigella dysentery. J Trop Med Hyg 85 : 195-199.
48. Hardy, A.V., Mason, R.P. and Martin, G.A. (1952): The antibiotics in acute bacillary dysentery. Ann NY Acad Sci 55 : 1070-1074.
49. Garfinkel, B.T., Martin, G.M., Watt, J., Payne, F.J., Mason, R.P. and Hardy, A.V. (1953): Antibiotics in acute bacillary dysentery. JAMA 151 : 1157-1159.
50. Kabir, I., Rahaman, M.M., Ahmed, S.M., Akhter, S.Q. and Butler, T. (1984): Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis. Antimicrob Agents Chernother 25 : 643-645.
51. Varsano, I., Eidlitz-Marcus, T., Nussinovitch, M. and Elian, I. (1991): Comparative efficacy of ceftrtiaxone and ampicillin in the treatment of severe shigellosis in children. J Pediatr 118 : 627-632.
52. Frost, J.A., Willshaw, G.A., Barclay, E.A., Rowe, B., Lemmens, P. and Vandepitte, J. (1985): Plasmid characterization of drug-resistant Shigella dyenteriae 1 from an epidemic in Central Africa. J Hyg 94 : 163-172.
53. Pal, S.C. (1984): Epidemic bacillary dysentery in West Bengal, India. Lancet (letter) I : 1452.
54. Bennish, M., Eusof, A., Kay, B. and Wierzba, T. (1985): Multiresistant Shigella infections in Bangladesh (letter). Lancet ii : 441.
55. Panhotra, B.R., Desai, B. and Sharma, P.L. (1985): Nalidixic-acid-resistant Shigella dysenteriae 1 (letter). Lancet i : 763.
56. Chun, D., Cho, D.T., Seol, S.Y., Suh, M.H. and Lee, Y.C. (1984): R plasmid confering multiple drug resistance from shigella isolated in Korea. J Hyg 92 : 153-160.
57. Huq, M.I., Al-Ghamdi, M.A., Haider, K. and Alim, A.R.M.A. (1987): Antimicrobial susceptibility pattern of the clinical isolates of Shigella sp. in the eastern province of Saudi Arabia. Asian Med J 30 : 228-234.
58. Centres for Disease Control. (1986): Multiply resistant shigellosis in a day care center-Texas. MMWR 35 : 753-755.
59. Centres for Disease Control. (1987): Nationwide dissemination of multiply resistant Shigella sonnei following a common-source outbreak. MMWR 36 : 633-634.
60. Centres for Disease Control. Shigella dysenteriae type 1-Guatemala, 1991. MMWR 1991 ; 40 : 421-428.
61. Bratoeva, M.P. and John, J.F. Jr. (1989): Dissemination of trimethoprim-resistant clones of Shigella sonnei in Bulgaria. J Infect Dis 159 : 648-653.
62. Mitra, A.K., Kabir, I. and Hossain, M.A. (1990): Pivmecillinam-resistant Shigella dysenteriae type 1 infection in Bangladesh (letter). Lancet 335 : 1461-1462.
63. Bennish, M.L., Salam, M.A., Hossain, M.A., Myaux, J., Khan, E.H., Chakrabolty, J., Henry, F. and Ronsmans, C. (1992): Antimicrobial resistance of Shigella isolates in Bangladesh. 1983-1990: increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid. Clin Infect Dis 14 : 1055-1060.
64. Jewes, L.A. (1987): Antimicrobial therapy of non-typhi salmonella and shigella infection. J Antomicrob Chemother 19 : 557-560.
65. Salam, M.A. and Bennish, M.L. (1988): Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis. J Pediatr 113 : 901-907.
66. Rogerie, F., Ott, D., Vandepitte, J., Verbist, L., Lemmens, P. and Habiyaremye, I. (1986): Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults. Antimicrob Agents Chemother 29 : 883-886.
67. De Mol, P., Mets, T., Lagasse, R., Vandepitte, J., Mutwewingabo, A. and Butzler, J.P. (1987): Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid. J Antimicrob Chemother 19 : 695-698.
68. Gotuzzo, E., Oberhelman, R.A., Maguina, C., Berry, S.J., Yi, A. and Guzman, M., et al. (1989): Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprirn-sulfamethoxazole for acute shigellosis in adults. Antimicrob Agents Chernother 33 : 1101-1104.
69. Douidar, SM. and Snodgrass, W.R. (1989): Potential role of fluoroquinolones in pediatric infections. Rev Infect Dis 11 : 878-889.
70. Salam, M.A., Khan, W.A., Dliar, U. and Bennish, M.L. (1997): Randomized, double-blinded comparison of ciprofloxacin (CIP) suspension and pivamdinocillin (PIV) tablets in the treatment of shigellosis in children. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 28 - October 01, Toronto, Canada, Abstract No. LM 17. p367.
71. Pocket book of antimicrobial therapy and prevention. eds Gorbach, S.L., Mensa, J., Gatell, J.M. 1997. Williams and Wilkins. Baltimore, USA.
72. Manavathu, E.K., Fernandez, C.L., Cooperman, B.S. and Taylor, D.E. (1990): Molecular studies on the mechanism of tetracycline resistance mediated by Tet (O). Antimicrobial Agents Chemother 34 : 71-77.
73. Chopra, I. (1992): Efflux based antibiotic resistance mechanisms: the evidence for increasing prevalence. J Antimicrob Chemother 30 : 737-739.
74. Levy, S.B. (1992): Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Chemother 36 : 695-703.
75. Shaw, W.V. (1984): Bacterial Resistance to chloramphenicol. Br Med Bull 40 : 36-41.
76. Parent, R. and Roy, P.H. (1992): The chloramphenicol acetyltransferase gene of Tn2424: a new breed of cat. J Bacteriol 174 : 2891-2897.
77. Eady, A.E., Ross, J.I. and Cove, J.H. (1990): Multiple mechanisms of erythromycin resistance. J Antimicrob Chemother 26 : 461-471.
78. Spratt, B.G. (1975): Distinct penicillin binding proteins involved in the division, elongation and shape of Escherichia coli K 12. Proc Natl Acad Sci USA 72 : 2999-3003.
79. Handwerger, S. and Tomasz, A. (1985): Antibiotic tolerance among clinical isolates of bacteria. Rev Infect Dis 7 : 368-382.
80. Satta, G., Cornaglia, G., Mazzariol, A., Golini, G., Valisena, S. and Fontana, R. (1995): Target for bacteriostatic and bactericidal activities of β -lactam antibiotics against Escherichia coli resides in different penicillin-binding proteins. Antimicrob Agents Chemother 39 : 812-818.
81. Berenguer, J., de Pedro, M.A. and Yazquez, D. (1982): Induction of cell lysis in Escherichia coli: cooperative effect of nocardicin A and mecillinam. Antimicrob Agents Chemother 21 : 195-200.
82. Gutmann, L., Vincent, S., Billot-Klein, D., Acar, J.F., Mréina, E., Williamson, R. (1986): Involvement of penicillin-binding 2 with other penicillin-binding proteins in lysis of Escherichia coli by some beta-lactam antibiotics alone and in synergistic lytic effect of amdinocillin (mecillinam). Antimicrob Agents Chemother 30 : 906-912.
83. Sawai, T., Hiruma, R., Kawana, N., Kaneko, M., Taniyasu, F. and Inami, A. (1982): Outer membrane permeation of β -lactam antibiotics in Escherichia coli, Proteus mirabilis and Enterobacter cloacae. Antimicrob Agents Chemother 22 : 585-592.
84. Jaffé, A., Chabbert, Y.A. and Semonin, O. (1981): Role of porin proteins OmpF and OmpC in the permeation of β-lactams. Antimicrob Agents Chemother 22 : 942-948.
85. Hane, M.W. and Wood, T.H. (1969): Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies. J Bacteriol 99 : 238-241.
86. Rella, M. and Hass, D. (1982): Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of β -lactam antibiotics: mapping of chromosomal genes. Antimicrob Agents Chemother 22 : 242-249.
87. Gutmann, L., Williamson, R., Moreau, N., Kitzis, M., Collatz, E., Acar, J.F. and Goldstein, F.W. (1985): Crossresistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia. J Infect Dis 151 : 501-507.
88. Sanders, C.C., Sanders, W.E., Goering, R.V. and Werner, V. (1984): Selection of multiple antibiotic resistance by quinolones, β -lactams, and aminoglycosides with special reference to crossresistance between unrel ated drug classes. Antimicrob Agents Chemother 26 : 797-801.
89. Petrucelli, B.P., Murphy, O.S., Sanchez, J.L., Waltz, S., DeFraites, R., Gelnet, J., Herberberger, R.L., Echeverria, P. and Taylor, D.N. (1992): Treatment of traveler's diarrhea with ciprofloxacin and loperamide. J Infect Dis 165 : 557-560.
90. Goodman, L.J., Trenholme, G.M., Kaplan, R.L. and Segreti, J., et al. (1990): Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med 150 : 541-546.
91. Tauxe, R.V., Puhr, N.D., Wells, J.G., Hargett-Bean, N. and Plake, P.A. (1990): Antimicrobial resistance of Shigella isolates in the USA: the importance of international travelers. J Infect Dis 162 : 1107-1111.
92. Heikkilä, E., Siitonen, A., Jahkola, M., Fling, M. and Sundström, Huovinen, P. (1990): Increase of trimethoprim resistance among Shigella species, 1975-1988: analysis of resistance mechanisms. J Infect Dis 161 : 1242-1248.
93. Gross, R.J., Thomas, L.V. and Rowe, B. (1979): Shigella dysenteriae, Sh. flexneri, and Sh. boydii infections in England and Wales: the importance of foreign travel. BMJ, ii : 744.
94. Griffin, P.M., Tauxe, R.V., Redd, S.C., Purh, N.D., hargret-Bean, N. and Blake, P.A. (1989): Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study, Am J Epidemiol 129 : 1042-1051.
95. Lolekha, S., Vibulbandhitkit, S. and Poonyarit, P. (1991): Response to antimicrobial therapy for shigellosis in Thailand. Rev Infect Dis 13 (Suppl 4) : S342-S346.
96. Bennish, M.L. (1991): Potentially lethal complications of shigllosis. Rev Infect Dis 13 (Suppl 4) : S319-S324.
97. Struelens, M.J., Patte, D., Kabir, I., Salam, M.A., Nath, S.K. and Butler, T. (1991): Shigella septicemia: prevalence, risk factors, and outcome. J Infect Dis 152 : 784-790.
98. Rothstein, D.M., McGlynn, M., Bernan, V., McGahren, J., Zaccardi, J. and Cekleniak, N., et al. (1993): Detection of tetracyclines and efflux pump inhibitors. Antimicrob Agents Chemother 37 : 1624-1629.